BackIsracann Biosciences Overview

Isracann Biosciences Total Liabilities

Latest total liabilities for ISCNF: $3.9M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$3.91M
↑ 751.44% YoYΔ $3.45M vs prior year quarter

Peer trimmed avg / median

Loading

Isracann Biosciences Total Liabilities History

Loading

Isracann Biosciences vs. peers: Total Liabilities Comparison

Loading

Isracann Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Isracann Biosciences (ISCNF) FAQ

Isracann Biosciences (ISCNF) currently reports a total liabilities of $3.9M as of August 2022. That compares with $460K in the prior-year period — up 751.4% year over year. Use the charts on this page to explore Isracann Biosciences's total liabilities history and peer comparisons.

Isracann Biosciences's total liabilities increased from $460K to $3.9M — a 751.4% year-over-year increase (period ending August 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Isracann Biosciences reported $3.9M in total liabilities as of August 2022. That compares with $460K in the prior-year period — up 751.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $3.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Isracann Biosciences, and consider following ISCNF for alerts when major investors trade the stock.